Stockscreener 앱 받기
1.76
1.15%
0.02
시간 외 거래:
1.75
-0.01
-0.57%
전일 마감가:
$1.74
열려 있는:
$1.77
하루 거래량:
502.09K
Relative Volume:
1.39
시가총액:
$63.27M
수익:
$210.70K
순이익/손실:
$-21.37M
주가수익비율:
-1.60
EPS:
-1.1
순현금흐름:
$-21.10M
1주 성능:
-11.56%
1개월 성능:
+5.39%
6개월 성능:
-4.86%
1년 성능:
+62.21%
1일 변동 폭
$1.72
$1.82
1주일 범위
$1.55
$2.0499
52주 변동 폭
$1.00
$3.19
게인 테라퓨틱스 Stock (GANX) Company Profile
명칭
Gain Therapeutics Inc
전화
(301) 500-1556
주소
4800 HAMPDEN LANE, BETHESDA
GANX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.76 | 62.55M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
게인 테라퓨틱스 Stock (GANX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-12-06 | 개시 | ROTH MKM | Buy |
| 2024-08-14 | 재개 | Oppenheimer | Outperform |
| 2021-04-12 | 개시 | BTIG Research | Buy |
| 2021-04-12 | 개시 | Oppenheimer | Outperform |
게인 테라퓨틱스 주식(GANX)의 최신 뉴스
Is this a good reentry point in Gain Therapeutics Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
What indicators show strength in Gain Therapeutics Inc.2025 Volatility Report & Verified Entry Point Signals - Newser
How to use a screener to detect Gain Therapeutics Inc. breakoutsIPO Watch & Weekly Market Pulse Alerts - Newser
Live market analysis of Gain Therapeutics Inc.Trade Risk Assessment & Expert Approved Momentum Trade Ideas - Newser
Will Gain Therapeutics Inc. benefit from seasonalityJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - خودرو بانک
What drives Gain Therapeutics Inc.’s stock priceJuly 2025 Fed Impact & AI Forecast for Swing Trade Picks - خودرو بانک
Using Ichimoku Cloud for Gain Therapeutics Inc. technicalsWeekly Trade Summary & Weekly Stock Performance Updates - Newser
Visualizing Gain Therapeutics Inc. stock with heatmapsJuly 2025 Pullbacks & Daily Market Momentum Tracking - Newser
Ranking Gain Therapeutics Inc. among high performing stocks via toolsTrade Entry Summary & Verified Short-Term Plans - Newser
Forecasting Gain Therapeutics Inc. price range with options dataWeekly Investment Recap & Daily Stock Momentum Reports - Newser
T1 Energy Inc. shares rise 3.78% premarket after Gain Therapeutics extended Phase 1b trial of GT-02287. - AInvest
Is now a turning point for Gain Therapeutics Inc.July 2025 Momentum & Short-Term High Return Strategies - Newser
Gain Therapeutics: A High-Conviction Biotech Play in Parkinson’s Disease Innovation - AInvest
Price action breakdown for Gain Therapeutics Inc.Earnings Trend Report & Free Low Drawdown Momentum Trade Ideas - Newser
Analyzing recovery setups for Gain Therapeutics Inc. investorsJobs Report & Accurate Technical Buy Alerts - Newser
What’s next for Gain Therapeutics Inc. stock priceEarnings Summary Report & Weekly High Potential Stock Alerts - Newser
Gain Therapeutics Inc.’s volatility index tracking explainedEarnings Recap Summary & Risk Managed Investment Entry Signals - Newser
What data driven models say about Gain Therapeutics Inc.’s futureWatch List & Stepwise Trade Signal Guides - Newser
Does Gain Therapeutics Inc. have declining or rising EPSJuly 2025 Trade Ideas & Weekly High Conviction Ideas - خودرو بانک
Gain Therapeutics extends Phase 1b Parkinson’s drug trial to 12 months - Investing.com Australia
12-Month Extension Approved: Gain Therapeutics' Parkinson's Drug Trial Shows Promise in Safety Review - Stock Titan
Gain Therapeutics Inc. stock volume spike explained2025 Short Interest & Real-Time Volume Trigger Notifications - Newser
Is Gain Therapeutics Inc. a momentum stockWeekly Stock Recap & AI Powered Buy and Sell Recommendations - خودرو بانک
Is Gain Therapeutics Inc. stock a good pick for beginnersJuly 2025 PreEarnings & High Yield Equity Trading Tips - خودرو بانک
What the charts say about Gain Therapeutics Inc. todayMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
Gain Therapeutics Inc. recovery potential after sell offWeekly Trade Report & Technical Confirmation Trade Alerts - Newser
Developing predictive dashboards with Gain Therapeutics Inc. data2025 Earnings Surprises & Low Drawdown Investment Strategies - Newser
Is a relief rally coming for Gain Therapeutics Inc. holdersMarket Performance Report & Free Real-Time Volume Trigger Notifications - Newser
Real time alert setup for Gain Therapeutics Inc. performance2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
Sell Signal: Is Gain Therapeutics Inc. stock showing strong momentumTrade Exit Report & Weekly High Potential Stock Alerts - خودرو بانک
Is Gain Therapeutics Inc. benefiting from innovation trendsM&A Rumor & Daily Technical Stock Forecast Reports - خودرو بانک
Gain Therapeutics: Targeting Parkinson’s at the Cellular Level - The Globe and Mail
Gain Therapeutics: Advancing Science in the Fight Against Parkinson’s - The Globe and Mail
Is Gain Therapeutics Inc. stock showing strong momentum2025 Biggest Moves & Weekly Return Optimization Plans - خودرو بانک
게인 테라퓨틱스 (GANX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):